Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Akyva First In Human

NCT: NCT06956209 · RECRUITING

NCT IDNCT06956209
StatusRECRUITING
Start Date2025-09-24
Completion2028-09

Brief Summary

The goal of this study is to check if the study device, the Akyva System, is safe to use and to find out if it has any possible side effects. Researchers will see if the study device can help you urinate without the need for catheterization, which involves passing a catheter (small tube) into the bladder, and if there is improvement in the leftover urine amount in your bladder after urinating or trying to urinate.

Frequently Asked Questions

What is Akyva First In Human?

Akyva First In Human is a clinical trial registered under NCT06956209. Current status: RECRUITING.

What is the status of NCT06956209?

The current status of NCT06956209 (Akyva First In Human) is: RECRUITING.

When did Akyva First In Human start?

Akyva First In Human started on 2025-09-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.